Lentivirus-mediated RNAi knockdown of LMP2A inhibits the growth of nasopharyngeal carcinoma cell line C666-1 in vitro

Gene

Volumn 542, Issue 1, 2014, Pages 77-82

  Ying, Xinjiang ^a   Zhang, Ruxin ^a   Wang, Hong ^a   Teng, Yaoshu ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Latent membrane protein 2A; Lentivirus; Nasopharyngeal carcinoma; Proliferation; RNA interference

Indexed keywords

LENTIVIRUS VECTOR;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; LMP2A GENE; NASOPHARYNX CARCINOMA; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR GENE; WESTERN BLOTTING;

LENTIVIRUS;

LATENT MEMBRANE PROTEIN 2A; LENTIVIRUS; NASOPHARYNGEAL CARCINOMA; PROLIFERATION; RNA INTERFERENCE;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION; GENETIC THERAPY; HUMANS; LENTIVIRUS; NASOPHARYNGEAL NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; VIRAL MATRIX PROTEINS;

EID: 84897486447     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.03.020     Document Type: Article

References (25)

1. Brennan B. Nasopharyngeal carcinoma. Orphanet Journal of Rare Diseases 2006, 1.
2. Brooks L., Yao Q.Y., Rickinson A.B., Young L.S. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. Journal of Virology 1992, 66:2689-2697.
3. Busson P., McCoy R., Sadler R., Gilligan K., Tursz T., Raab-Traub N. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. Journal of Virology 1992, 66:3257-3262.
4. Dawson C.W., Port R.J., Young L.S. The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). Seminars in Cancer Biology 2012, 22:144-153.
5. Fire A., Xu S.Q., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391:806-811.
6. Fotheringham J.A., Coalson N.E., Raab-Traub N. Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk- and Akt-dependent epithelial migration through alpha V-integrin membrane translocation. Journal of Virology 2012, 86:10308-10320.
7. Fukuda M., Longnecker R. Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/P13-K/Akt pathway. Journal of Virology 2007, 81:9299-9306.
8. Heussinger N., Buttner M., Ott G., Brachtel E., Pilch B.Z., Kremmer E., Niedobitek G. Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma. Journal of Pathology 2004, 203:696-699.
9. Ikeda M., Fukuda M., Longnecker R. Function of latent membrane protein 2A. Epstein-Barr Virus 2005, 533-552.
10. Izquierdo M. Short interfering RNAs as a tool for cancer gene therapy. Cancer Gene Therapy 2005, 12:217-227.
11. Kieff E. Epstein-Barr Virus and Its Replication 1996.
12. Kong Q.-L., Hu L.-J., Cao J.-Y., Huang Y.-J., Xu L.-H., Liang Y., Xiong D., Guan S., Guo B.-H., Mai H.-Q., Chen Q.-Y., Zhang X., Li M.-Z., Shao J.-Y., Qian C.-N., Xia Y.-F., Song L.-B., Zeng Y.-X., Zeng M.-S. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathogens 2010, 6.
13. Lan Y.-Y., Hsiao J.-R., Chang K.-C., Chang J.S.-M., Chen C.-W., Lai H.-C., Wu S.-Y., Yeh T.-H., Chang F.-H., Lin W.-H., Su I.-J., Chang Y. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9. Journal of Virology 2012, 86:6656-6667.
14. Lu J., Lin W.H., Chen S.Y., Longnecker R., Tsai S.C., Chen C.L., Tsai C.H. Syk tyrosine kinase mediates Epstein-Barr virus latent membrane protein 2A-induced cell migration in epithelial cells. Journal of Biological Chemistry 2006, 281:8806-8814.
15. Morrison J.A., Raab-Traub N. Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of beta-catenin signaling. Journal of Virology 2005, 79:2375-2382.
16. Pan X.-B., Zhu X.-D. Role of chemotherapy in stage IIb nasopharyngeal carcinoma. Chinese Journal of Cancer 2012, 31:573-578.
17. Pan Y.-R., Vatsyayan J., Chang Y.-S., Chang H.-Y. Epstein-Barr virus latent membrane protein 2A upregulates UDP-glucose dehydrogenase gene expression via ERK and PI3K/Akt pathway. Cellular Microbiology 2008, 10:2447-2460.
18. Pang M.-F., Lin K.-W., Peh S.-C. The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer. Cellular & Molecular Biology Letters 2009, 14:222-247.
19. Pegtel D.M., Subramanian A., Sheen T.S., Tsai C.H., Golub T.R., Thorley-Lawson D.A. Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis. Journal of Virology 2005, 79:15430-15442.
20. Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Epstein-Barr Virus 2005, 71-92.
21. Scholle F., Bendt K.M., Raab-Traub N. Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. Journal of Virology 2000, 74:10681-10689.
22. Stewart S., Dawson C.W., Takada K., Curnow J., Moody C.A., Sixbey J.W., Young L.S. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappa B transcription factor pathway. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:15730-15735.
23. Swart R., Ruf I.K., Sample J., Longnecker R. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-kinase/Akt pathway. Journal of Virology 2000, 74:10838-10845.
24. Xiao W.-W., Han F., Lu T.-X., Chen C.-Y., Huang Y., Zhao C. Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma. International Journal of Radiation Oncology, Biology, Physics 2009, 74:1070-1076.
25. Zhang Z., Wang J., Shen B., Peng C., Zheng M. The ABCC4 gene is a promising target for pancreatic cancer therapy. Gene 2012, 491:194-199.